About LayerBio
LayerBio is a company based in Boston (United States) founded in 2013 was acquired by PainReform in July 2025.. LayerBio has raised $805 thousand across 6 funding rounds from investors including PainReform, HHS and National Science Foundation. LayerBio offers products and services including OcuRing. LayerBio operates in a competitive market with competitors including Sirnaomics, Acorda, Liquidia, Genedit and Eyenovia, among others.
- Headquarter Boston, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Layerbio, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$805 K (USD)
in 6 rounds
-
Latest Funding Round
$600 K (USD), Seed
Jul 10, 2025
-
Investors
PainReform
& 2 more
-
Employee Count
Employee Count
-
Acquired by
PainReform
(Jul 10, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LayerBio
LayerBio offers a comprehensive portfolio of products and services, including OcuRing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bioerodible sustained-release tech for intraocular lenses in cataract surgery.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of LayerBio
LayerBio has successfully raised a total of $805K across 6 strategic funding rounds. The most recent funding activity was a Seed round of $600 thousand completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Seed — $600,000
-
First Round
First Round
(20 Jul 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Seed - LayerBio | Valuation |
investors |
|
| Jul, 2020 | Amount | Grant - LayerBio | Valuation |
investors |
|
| May, 2018 | Amount | Grant - LayerBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LayerBio
LayerBio has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include PainReform, HHS and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Pain treatment products are developed through reformulation technologies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LayerBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LayerBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Layerbio Comparisons
Competitors of LayerBio
LayerBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Acorda, Liquidia, Genedit and Eyenovia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| domain | founded_year | HQ Location |
Engineered particles & films for life and material sciences applications
|
|
| domain | founded_year | HQ Location |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| domain | founded_year | HQ Location |
Microdose therapies for myopia treatment are developed with Optejet dispenser.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Layerbio
Frequently Asked Questions about LayerBio
When was LayerBio founded?
LayerBio was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is LayerBio located?
LayerBio is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is LayerBio a funded company?
LayerBio is a funded company, having raised a total of $805K across 6 funding rounds to date. The company's 1st funding round was a Grant of $1.23M, raised on Jul 20, 2014.
What does LayerBio do?
LayerBio was founded in 2013 in Boston, United States, focusing on biotechnology for ophthalmology and wound care sectors. Operations center on LayerForm technology, derived from MITs layer-by-layer fabrication methods. A biodegradable nanoparticle system is being developed for sustained release of an FDA-approved glaucoma drug, alongside a drug-eluting intraocular lens for cataract surgery applications.
Who are the top competitors of LayerBio?
LayerBio's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
What products or services does LayerBio offer?
LayerBio offers OcuRing.
Who are LayerBio's investors?
LayerBio has 3 investors. Key investors include PainReform, HHS, and National Science Foundation.